Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	546.74	621.39	478.02	446.62	326.91	1,037
Revenue Growth (YoY)	-12.54%	29.99%	7.03%	36.62%	-68.48%	651.46%
Cost of Revenue	116.14	127.53	140.51	173.94	77.24	112.36
Gross Profit	430.6	493.86	337.51	272.67	249.67	924.74
Selling, General & Admin	152.85	149.62	99.11	90.84	83.96	153.41
Research & Development	109.73	97.17	53.11	72.18	31.11	59.41
Other Operating Expenses	4.63	3.01	1.44	8.89	2.87	8.15
Operating Expenses	249.65	253.83	158.57	178.08	117.58	221.05
Operating Income	180.96	240.03	178.94	94.59	132.09	703.68
Interest Expense	-0.1	-0.11	-0.2	-0.41	-0.13	-0.18
Interest & Investment Income	31.12	30.74	24.57	12.11	3.59	4.12
Currency Exchange Gain (Loss)	1.14	1.14	0.57	42.65	-9.76	-34.85
Other Non Operating Income (Expenses)	-4.2	-3.92	0.34	-0.6	-0.11	-0.08
EBT Excluding Unusual Items	208.92	267.87	204.22	148.35	125.68	672.7
Gain (Loss) on Sale of Investments	6.29	7.46	9.15	2.23	0.89	0.12
Gain (Loss) on Sale of Assets	-0.11	-0.1	-0.01	0.01	-	-
Asset Writedown	-1.39	-	-19.54	-	-0	-0.09
Other Unusual Items	1.28	1.29	4.54	13.92	11.24	1.71
Pretax Income	214.98	276.53	198.36	164.51	137.81	674.45
Income Tax Expense	18.92	29.67	24.41	13.82	17.65	102.64
Earnings From Continuing Operations	196.06	246.86	173.95	150.68	120.16	571.81
Minority Interest in Earnings	-	-	-	-	0.09	-0.36
Net Income	196.06	246.86	173.95	150.68	120.25	571.45
Net Income to Common	196.06	246.86	173.95	150.68	120.25	571.45
Net Income Growth	-26.35%	41.92%	15.44%	25.31%	-78.96%	2584.36%
Shares Outstanding (Basic)	136	136	136	122	102	99
Shares Outstanding (Diluted)	136	136	136	122	102	99
Shares Change (YoY)	-0.08%	0.36%	11.83%	19.24%	2.90%	286.30%
EPS (Basic)	1.44	1.81	1.28	1.24	1.18	5.77
EPS (Diluted)	1.44	1.81	1.28	1.24	1.18	5.77
EPS Growth	-26.29%	41.41%	3.23%	5.08%	-79.55%	594.89%
Free Cash Flow	262.22	269.31	242.89	68.71	42.52	563.1
Free Cash Flow Per Share	1.92	1.98	1.79	0.56	0.42	5.69
Dividend Per Share	-	-	0.400	0.166	-	-
Dividend Growth	-	-	140.96%	-	-	-
Gross Margin	78.76%	79.48%	70.60%	61.05%	76.37%	89.17%
Operating Margin	33.10%	38.63%	37.43%	21.18%	40.41%	67.85%
Profit Margin	35.86%	39.73%	36.39%	33.74%	36.79%	55.10%
Free Cash Flow Margin	47.96%	43.34%	50.81%	15.38%	13.01%	54.30%
EBITDA	198.83	258.72	200.92	111.08	145.29	709.09
EBITDA Margin	36.37%	41.64%	42.03%	24.87%	44.45%	68.37%
D&A For EBITDA	17.87	18.7	21.98	16.49	13.21	5.4
EBIT	180.96	240.03	178.94	94.59	132.09	703.68
EBIT Margin	33.10%	38.63%	37.43%	21.18%	40.41%	67.85%
Effective Tax Rate	8.80%	10.73%	12.31%	8.40%	12.80%	15.22%
Revenue as Reported	546.74	621.39	478.02	446.62	326.91	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.